It all started with an invention
SamanTree Medical is born out of a novel ultra-fast confocal microscopy technology invented at EPFL (Switzerland) in 2010. This innovation has found its application in cancer treatment, where it enables medical professionals to identify and remove cancerous tissue with unique accuracy and speed. By allowing for real-time imaging from biopsy taking to intraoperative decision making, this technology can help to improve patient treatment plans and outcomes, making it a crucial tool in the fight against cancer.
A collaborative approach to healthcare
At SamanTree Medical, we believe that the key to creating impactful medical technologies is through close collaboration with clinicians. By working closely with healthcare professionals, we gain valuable insights into their needs and are better able to develop solutions that truly make a difference in the lives of patients.
These partnerships combined with our innovative thinking ensure that we remain at the forefront of the medical imaging industry, supplying cutting-edge solutions that enable clinicians to provide the best possible care for their patients.
Disrupting the status quo in the world of cancer treatment
We're fired up to bring our game-changing technology to the world, as we’ve already changed the practice in numerous centers throughout Europe and beyond. With a laser focus on growth and expansion, we're committed to making a real difference in the lives of people around the globe.
Our partners
Clinical partners
Aalst Hospital, Aalst (Belgium)
St. Vincenz Hospital, Paderborn (Germany)
AUSL-IRCCS Reggio Emilia (Italy)
Cantonal Hospital of Fribourg (Switzerland)
Valais Hospital, Sion (Switzerland)
University College London Hospital (UK)
Canisius Wilhelmina Hospital, Nijmegen (Netherlands)
Distributors
AxLab (UK, Nordics, BeNeLux)
Movi (Italy)
OncoLógica Sistemas (Spain & Portugal)
Histocom (Austria)
Biameditek (Poland)
Bamed (Czechia, Slovakia)
SOFMEDICA (Romania, Bulgaria, Hungary)
Medapp Healthcare Technology ltd, Athens (Greece)
Spektra Medikal (Turkey)
What we believe in
Patient-centered care
Our ultimate objective is to enhance the quality of life for cancer patients. We always keep in mind the significance of prioritizing patients and carrying out our work with empathy and compassion.
Constant innovation
In an ever-evolving field such as medical devices for cancer surgery, keeping up with the latest advancements and continuously seeking ways to improve is critical. We take a proactive approach to our work and stay abreast of the latest research and developments.
Collaborative approach
Developing and manufacturing a medical device is a complex and collaborative process involving multiple teams and external stakeholders. We strive to achieve the best possible results by focusing on expertise and ideas exchange.
Our values drive our work, and our team makes it happen.
The technology
We have re-invented confocal microscopy to make it compatible with the intraoperative environment
The Histolog Scanner employs a cutting-edge technology called massive parallel confocal microscopy as its core technology. This expands the imaging field by up to 40,000 times larger than standard confocal microscopy. With this capability, clinicians can now visualize large fresh tissue samples in real-time with remarkable resolution and accuracy.
The medical ISO certification is a crucial component of our commitment to quality, safety, and excellence in all aspects of our operations, from research and development to manufacturing and distribution. It is a symbol of our dedication to meeting the needs of our customers, the healthcare industry, and the patients who rely on our products and services.
Certificate: EN ISO 13485:2016 (MD 671824)
ISO 13485 compliance to deliver excellence
Investors
